Title : Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, reduces bodyweight and fat mass, but not muscle mass, in Japanese type 2 diabetes patients treated with insulin: A randomized clinical trial.

Pub. Date : 2019 Jul

PMID : 30536746






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, reduces bodyweight and fat mass, but not muscle mass, in Japanese type 2 diabetes patients treated with insulin: A randomized clinical trial. ipragliflozin solute carrier family 5 member 2 Homo sapiens